BUFEXAMAC
UNII 4T3C38J78L

Substance Identification & Data

This profile provides standardized clinical and technical data for Bufexamac, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4T3C38J78L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2438-72-4 and the RxNorm Concept ID (RxCUI) 1796. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4T3C38J78L

CAS Registry Number

2438-72-4

RxNorm Concept ID

1796

Detailed Substance Profile

Preferred Name

BUFEXAMAC

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C12H17NO3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MXJWRABVEGLYDG-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C166783

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

2466

Unique identification number in the NCBI database of chemical substances.

INN ID

2557

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(Cc1ccc(cc1)OCCCC)(NO)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bufexamac. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.